Advertisement

Lyme Disease

  • Roger P. Clark
  • Linden T. Hu
Chapter

In the short period of time since Lyme disease was first described in the mid-1970 s, it has rapidly become recognized as the most common vector-borne illness in the United States. In 1982, the Centers for Disease Control and Prevention (CDC) began surveillance of Lyme disease, and the CSTE (Council of State and Territorial Epidemiologists) classified Lyme disease as a notifiable disease in 1990.

Keywords

Blood Meal Lyme Disease Borrelia Burgdorferi Lyme Borreliosis Erythema Migrans 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Adelson, M. E., R. V. Rao, R. C. Tilton, K. Cabets, E. Eskow, L. Fein, J. L. Occi and E. Mordechai (2004). “Prevalence of Borrelia burgdorferi, Bartonella spp., Babesia microti, and Anaplasma phagocytophila in Ixodes scapularis ticks collected in Northern New Jersey." J Clin Microbiol 42(6): 2799–801.PubMedGoogle Scholar
  2. 2.
    Anderson, J. F., R. C. Johnson, L. A. Magnarelli and F. W. Hyde (1986). “Involvement of birds in the epidemiology of the Lyme disease agent Borrelia burgdorferi." Infect Immun 51(2): 394–6.PubMedGoogle Scholar
  3. 3.
    Asbrink, E. (1985). “Erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Early and late manifestations of Ixodes ricinus-borne Borrelia spirochetes." Acta Derm Venereol Suppl (Stockh) 118: 1–63.Google Scholar
  4. 4.
    Asbrink, E (1985). ``Erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Early and late manifestations of Ixodes ricinus-borne Borrelia spirochetes.’ Acta Derm Venereol. Supplementum 118:1.Google Scholar
  5. 5.
    Asbrink, E. and A. Hovmark (1988). “Early and late cutaneous manifestations in Ixodes-borne borreliosis (erythema migrans borreliosis, Lyme borreliosis)." Ann N Y Acad Sci 539: 4–15.PubMedGoogle Scholar
  6. 6.
    Barbour, A. G. (1984). “Isolation and cultivation of Lyme disease spirochetes." Yale J Biol Med 57(4): 521–5.PubMedGoogle Scholar
  7. 7.
    Berglund, J., R. Eitrem, K. Ornstein, A. Lindberg, A. Ringer, H. Elmrud, M. Carlsson, A. Runehagen, C. Svanborg and R. Norrby (1995). “An epidemiologic study of Lyme disease in southern Sweden." N Engl J Med 333(20): 1319–27.PubMedGoogle Scholar
  8. 8.
    Bockenstedt, L. K., J. Mao, E. Hodzic, S. W. Barthold and D. Fish (2002). “Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment." J Infect Dis 186(10): 1430–7.PubMedGoogle Scholar
  9. 9.
    Burgdorfer, W., A. G. Barbour, S. F. Hayes, J. L. Benach, E. Grunwaldt and J. P. Davis (1982). “Lyme disease-a tick-borne spirochetosis?" Science 216(4552): 1317–9.PubMedGoogle Scholar
  10. 10.
    Burkot, T. R., G. R. Mullen, R. Anderson, B. S. Schneider, C. M. Happ and N. S. Zeidner (2001). “Borrelia lonestari DNA in adult Amblyomma americanum ticks, Alabama." Emerg Infect Dis 7(3): 471–3.PubMedGoogle Scholar
  11. 11.
    Coburn, J., J. M. Leong and J. K. Erban (1993). “Integrin alpha IIb beta 3 mediates binding of the Lyme disease agent Borrelia burgdorferi to human platelets." Proc Natl Acad Sci U S A 90(15): 7059–63.PubMedGoogle Scholar
  12. 12.
    Coleman, J. L., T. J. Sellati, J. E. Testa, R. R. Kew, M. B. Furie and J. L. Benach (1995). “Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers." Infect Immun 63(7): 2478–84.PubMedGoogle Scholar
  13. 13.
    Coyle, B. S., G. T. Strickland, Y. Y. Liang, C. Pena, R. McCarter and E., Israel (1996). ``The public health impact of Lyme disease in Maryland.’ J Infect Dis ;173:1260–2.Google Scholar
  14. 14.
    da Franca, I., L. Santos, T. Mesquita, M. Collares-Pereira, S. Baptista, L. Vieira, I. Viana, E. Vale and C. Prates (2005). ``Lyme borreliosis in Portugal caused by Borrelia lusitaniae? Clinical report on the first patient with a positive skin isolate.’ Wiener Klinische Wochenschrift 117:429.Google Scholar
  15. 15.
    Dattwyler, R. J., B. J. Luft, M. J. Kunkel, M. F. Finkel, G. P. Wormser, T. J. Rush, E. Grunwaldt, W. A. Agger, M. Franklin, D. Oswald, L. Cockey and D. Maladorno (1997). “Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease." N Engl J Med 337(5): 289–94.PubMedGoogle Scholar
  16. 16.
    Davis, J. P., W. L. Schell, T. E. Amundson, M. S. Godsey, Jr., A. Spielman, W. Burgdorfer, A. G. Barbour, M. LaVenture and R. A. Kaslow (1984). “Lyme disease in Wisconsin: epidemiologic, clinical, serologic, and entomologic findings." Yale J Biol Med 57(4): 685–96.PubMedGoogle Scholar
  17. 17.
    Duncan, A. W., M. T. Correa, J. F. Levine and E. B. Breitschwerdt (2004). “The dog as a sentinel for human infection: prevalence of Borrelia burgdorferi C6 antibodies in dogs from southeastern and mid-Atlantic states." Vector Borne Zoonotic Dis 4(3): 221–9.PubMedGoogle Scholar
  18. 18.
    Engstrom, S. M., E. Shoop and R. C. Johnson (1995). “Immunoblot interpretation criteria for serodiagnosis of early Lyme disease." J Clin Microbiol 33(2): 419–27.PubMedGoogle Scholar
  19. 19.
    Eppes, S. C., D. K. Nelson, L. L. Lewis and J. D. Klein (1999). “Characterization of Lyme meningitis and comparison with viral meningitis in children." Pediatrics 103(5 Pt 1): 957–60.PubMedGoogle Scholar
  20. 20.
    Evans, S. R., G. W. Korch, Jr. and M. A. Lawson (1990). “Comparative field evaluation of permethrin and deet-treated military uniforms for personal protection against ticks (Acari)." J Med Entomol 27(5): 829–34.PubMedGoogle Scholar
  21. 21.
    Fingerle, V., U. Hauser, G. Liegl, B. Petko, V. Preac-Mursic and B. Wilske (1995). “Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus." J Clin Microbiol 33(7): 1867–9.PubMedGoogle Scholar
  22. 22.
    Fraser, C. M., S. Casjens, W. M. Huang, G. G. Sutton, R. Clayton,f R. Lathigra, O. White, K. A. Ketchum, R. Dodson, E. K. Hickey, M. Gwinn, B. Dougherty, J. F. Tomb, R. D. Fleischmann, D. Richardson, J. Peterson, A. R. Kerlavage, J. Quackenbush, S. Salzberg, M. Hanson, R. van Vugt, N. Palmer, M. D. Adams, J. Gocayne, J. Weidman, T. Utterback, L. Watthey, L. McDonald, P. Artiach, C. Bowman, S. Garland, C. Fuji, M. D. Cotton, K. Horst, K. Roberts, B. Hatch, H. O. Smith and J. C. Venter (1997). “Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi." Nature 390(6660): 580–6.PubMedGoogle Scholar
  23. 23.
    Fuchs, H., R. Wallich, M. M. Simon and M. D. Kramer (1994). “The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor." Proc Natl Acad Sci U S A 91(26): 12594–8.PubMedGoogle Scholar
  24. 24.
    Gerberg, E. J. and R. J. Novak (2002). “Insect repellents and mosquito bites." N Engl J Med 347(21): 1719–21; author reply 1719–21.PubMedGoogle Scholar
  25. 25.
    Gern, L., A. Estrada-Pena, F. Frandsen, J. S. Gray, T. G. Jaenson, F. Jongejan, O. Kahl, E. Korenberg, R. Mehl and P. A. Nuttall (1998). “European reservoir hosts of Borrelia burgdorferi sensu lato." Zentralbl Bakteriol 287(3): 196–204.PubMedGoogle Scholar
  26. 26.
    Gilmore, R. D., Jr. and J. Piesman (2000). “Inhibition of Borrelia burgdorferi migration from the midgut to the salivary glands following feeding by ticks on OspC-immunized mice." Infect Immun 68(1): 411–4.PubMedGoogle Scholar
  27. 27.
    Goldstein, S. F., K. F. Buttle and N. W. Charon (1996). “Structural analysis of the Leptospiraceae and Borrelia burgdorferi by high-voltage electron microscopy." J Bacteriol 178(22): 6539–45.PubMedGoogle Scholar
  28. 28.
    Grimm, D., K. Tilly, R. Byram, P. E. Stewart, J. G. Krum, D. M. Bueschel, T. G. Schwan, P. F. Policastro, A. F. Elias and P. A. Rosa (2004). “Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals." Proc Natl Acad Sci U S A 101(9): 3142–7.PubMedGoogle Scholar
  29. 29.
    Halperin, J. J. (1998). “Nervous system Lyme disease." J Neurol Sci 153(2): 182–91.PubMedGoogle Scholar
  30. 30.
    Hodzic E., S. Feng, K. Holden, K. J. Freet and S. W. Barthold (2008). ``Persistence of Borrelia burgdorferi following antibiotic treatment in mice.’ Antimicrob Agents Chemother. 52(5):1728–36.Google Scholar
  31. 31.
    Hovind-Hougen, K. (1984). “Ultrastructure of spirochetes isolated from Ixodes ricinus and Ixodes dammini." Yale J Biol Med 57(4): 543–8.PubMedGoogle Scholar
  32. 32.
    Hu, L. T., M. A. Eskildsen, C. Masgala, A. C. Steere, E. C. Arner, M. A. Pratta, A. J. Grodzinsky, A. Loening and G. Perides (2001). “Host metalloproteinases in Lyme arthritis." Arthritis Rheum 44(6): 1401–10.PubMedGoogle Scholar
  33. 33.
    Hu, L. T., G. Perides, R. Noring and M. S. Klempner (1995). “Binding of human plasminogen to Borrelia burgdorferi." Infect Immun 63(9): 3491–6.PubMedGoogle Scholar
  34. 34.
    Hunfeld, K. P., E. Ruzic-Sabljic, et al. (2005). “In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy." Antimicrob Agents Chemother 49(4): 1294–301.PubMedGoogle Scholar
  35. 35.
    Johnson, R. C., N. Marek and C. Kodner (1984). “Infection of Syrian hamsters with Lyme disease spirochetes." J Clin Microbiol 20(6): 1099–101.PubMedGoogle Scholar
  36. 36.
    Kalish, R. (1993). “Lyme disease." Rheum Dis Clin North Am 19(2): 399–426.PubMedGoogle Scholar
  37. 37.
    Kalish, R. A., J. M. Leong and A. C. Steere (1993). “Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi." Infect Immun 61(7): 2774–9.PubMedGoogle Scholar
  38. 38.
    Kalish, R. S., J. A. Wood, W. Golde, R. Bernard, L. E. Davis, R. C. Grimson, P. K. Coyle and B. J. Luft (2003). “Human T lymphocyte response to Borrelia burgdorferi infection: no correlation between human leukocyte function antigen type 1 peptide response and clinical status." J Infect Dis 187(1): 102–8.PubMedGoogle Scholar
  39. 39.
    Keller, D., F. T. Koster, D. H. Marks, P. Hosbach, L. F. Erdile and J. P. Mays (1994). “Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine." JAMA 271(22): 1764–8.PubMedGoogle Scholar
  40. 40.
    Kirkland, K. B., T. B. Klimko, R. A. Meriwether, M. Schriefer, M. Levin, J. Levine, W. R. Mac Kenzie and D. T. Dennis (1997). “Erythema migrans-like rash illness at a camp in North Carolina: a new tick-borne disease?" Arch Intern Med 157(22): 2635–41.PubMedGoogle Scholar
  41. 41.
    Klempner, M. S., R. Noring, M. P. Epstein, B. McCloud, R. Hu, S. A. Limentani and R. A. Rogers (1995). “Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi." J Infect Dis 171(5): 1258–65.PubMedGoogle Scholar
  42. 42.
    Krause, P. J., S. R. Telford, 3rd, A. Spielman, V. Sikand, R. Ryan, D. Christianson, G. Burke, P. Brassard, R. Pollack, J. Peck and D. H. Persing (1996). “Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness." JAMA 275(21): 1657–60.PubMedGoogle Scholar
  43. 43.
    Labandeira-Rey, M. and J. T. Skare (2001). “Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28–1." Infect Immun 69(1): 446–55.PubMedGoogle Scholar
  44. 44.
    Lane, R. S. and W. Burgdorfer (1988). “Spirochetes in mammals and ticks (Acari: Ixodidae) from a focus of Lyme borreliosis in California." J Wildl Dis 24(1): 1–9.PubMedGoogle Scholar
  45. 45.
    Levin, M., J. F. Levine, C. S. Apperson, D. E. Norris and P. B. Howard (1995). “Reservoir competence of the rice rat (Rodentia: Cricetidae) for Borrelia burgdorferi." J Med Entomol 32(2): 138–42.PubMedGoogle Scholar
  46. 46.
    Lipsker, D., Y. Hansmann, F. Limbach, C. Clerc, C. Tranchant, F. Grunenberger, F. Caro-Sampara, P. Attali, M. Frey, M. Kubina, Y. Piemont, J. Sibilia and B. Jaulhac (2001). “Disease expression of Lyme borreliosis in northeastern France." Eur J Clin Microbiol Infect Dis 20(4): 225–30.PubMedGoogle Scholar
  47. 47.
    Ludin, C. E., D. Nadal and H. E. Gnehm (1986). “[Lyme disease (erythema migrans disease)]." Ther Umsch 43(7): 537–9.PubMedGoogle Scholar
  48. 48.
    Malawista, W. E., S. W. Barthold, et al. (1994). “Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment." J Infect Dis 170: 1312–6.PubMedGoogle Scholar
  49. 49.
    Marconi, R. T., D. S. Samuels and C. F. Garon (1993). “Transcriptional analyses and mapping of the ospC gene in Lyme disease spirochetes." J Bacteriol 175(4): 926–32.PubMedGoogle Scholar
  50. 50.
    Markowitz, L. E., A. C. Steere, J. L. Benach, J. D. Slade and C. V. Broome (1986). “Lyme disease during pregnancy." JAMA 255(24): 3394–6.PubMedGoogle Scholar
  51. 51.
    Marques, A. R., D. S. Martin and M. T. Philipp (2002). “Evaluation of the C6 peptide enzyme-linked immunosorbent assay for individuals vaccinated with the recombinant OspA vaccine." J Clin Microbiol 40(7): 2591–3.PubMedGoogle Scholar
  52. 52.
    Matuschka, F. R., H. Eiffert, A. Ohlenbusch, D. Richter, E. Schein and A. Spielman (1994). “Transmission of the agent of Lyme disease on a subtropical island." Trop Med Parasitol 45(1): 39–44.PubMedGoogle Scholar
  53. 53.
    Maupin, G. O., D. Fish, J. Zultowsky, E. G. Campos and J. Piesman (1991). “Landscape ecology of Lyme disease in a residential area of Westchester County, New York." Am J Epidemiol 133(11): 1105–13.PubMedGoogle Scholar
  54. 54.
    McAlister, H. F., P. T. Klementowicz, C. Andrews, J. D. Fisher, M. Feld and S. Furman (1989). “Lyme carditis: an important cause of reversible heart block." Ann Intern Med 110(5): 339–45.PubMedGoogle Scholar
  55. 55.
    McDowell, J. V., S. Y. Sung, M. Labandeira-Rey, J. T. Skare and R. T. Marconi (2001). “Analysis of mechanisms associated with loss of infectivity of clonal populations of Borrelia burgdorferi B31MI." Infect Immun 69(6): 3670–7.PubMedGoogle Scholar
  56. 56.
    Mehnert, W. H. and G. Krause (2005). “Surveillance of Lyme borreliosis in Germany, 2002 and 2003." Euro Surveill 10(4): 83–5.PubMedGoogle Scholar
  57. 57.
    Mitchell, P. D., K. D. Reed and J. M. Hofkes (1996). “Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota." J Clin Microbiol 34(3): 724–7.PubMedGoogle Scholar
  58. 58.
    MMWR (1991). ``Current trends in Lyme Disease surveillance – United States, 1989–1990’. 40(25);417–421, 28 June.Google Scholar
  59. 59.
    MMWR (1997). ``Case definitions for infectious conditions under public health surveillance’. 46(RR10);1–55, 02 May.Google Scholar
  60. 60.
    MMWR (2004). ``Lyme Disease – United States, 2001–2002’. 53(17);365–369,7 May.Google Scholar
  61. 61.
    MMWR (2005). ``Notice to readers: Caution regarding testing for Lyme Disease’. 54(05);125, 11 February.Google Scholar
  62. 62.
    MMWR (2007). ``Lyme Disease – United States, 2003–2005.’ 56(23);573–576, 15 June.Google Scholar
  63. 63.
    Mogilyansky, E., C. C. Loa, M. E. Adelson, E. Mordechai and R. C. Tilton (2004). “Comparison of Western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease." Clin Diagn Lab Immunol 11(5): 924–9.PubMedGoogle Scholar
  64. 64.
    Nadal, D., U. A. Hunziker, H. U. Bucher, W. H. Hitzig and G. Duc (1989). “Infants born to mothers with antibodies against Borrelia burgdorferi at delivery." Eur J Pediatr 148(5): 426–7.PubMedGoogle Scholar
  65. 65.
    Nadelman, R. B., J. Nowakowski, D. Fish, R. C. Falco, K. Freeman, D. McKenna, P. Welch, R. Marcus, M. E. Aguero-Rosenfeld, D. T. Dennis and G. P. Wormser (2001). “Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite." N Engl J Med 345(2): 79–84.PubMedGoogle Scholar
  66. 66.
    Nefedova, V. V., E. I. Korenberg, N. B. Gorelova and Y. V. Kovalevskii (2004). “Studies on the transovarial transmission of Borrelia burgdorferi sensu lato in the taiga tick Ixodes persulcatus." Folia Parasitol (Praha) 51(1): 67–71.Google Scholar
  67. 67.
    Nocton, J. J. and A. C. Steere (1995). “Lyme disease." Adv Intern Med 40: 69–117.PubMedGoogle Scholar
  68. 68.
    Nowakowski, J., D. McKenna, et al. (2000). “Failure of treatment with cephalexin for Lyme disease." Arch Fam Med 9(6): 563–7.PubMedGoogle Scholar
  69. 69.
    Nuttall, P. A. and M. Labuda (2004). “Tick-host interactions: saliva-activated transmission." Parasitology 129 Suppl: 177–89.Google Scholar
  70. 70.
    Oliver, J. H., Jr., T. M. Kollars, Jr., F. W. Chandler, Jr., A. M. James, E. J. Masters, R. S. Lane and L. O. Huey (1998). “First isolation and cultivation of Borrelia burgdorferi sensu lato from Missouri." J Clin Microbiol 36(1): 1–5.PubMedGoogle Scholar
  71. 71.
    Olsen, B., T. G. Jaenson and S. Bergstrom (1995). “Prevalence of Borrelia burgdorferi sensu lato-infected ticks on migrating birds." Appl Environ Microbiol 61(8): 3082–7.PubMedGoogle Scholar
  72. 72.
    Pal, U., A. M. de Silva, R. R. Montgomery, D. Fish, J. Anguita, J. F. Anderson, Y. Lobet and E. Fikrig (2000). “Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A." J Clin Invest 106(4): 561–9.PubMedGoogle Scholar
  73. 73.
    Parveen, N. and J. M. Leong (2000). “Identification of a candidate glycosaminoglycan-binding adhesin of the Lyme disease spirochete Borrelia burgdorferi." Mol Microbiol 35(5): 1220–34.PubMedGoogle Scholar
  74. 74.
    Pound, J. M., J. A. Miller, J. E. George and C. A. Lemeilleur (2000). The `4-poster’ passive topical treatment device to apply acaricide for controlling ticks (Acari: Ixodidae) feeding on white-tailed deer, J Med Entomol. 37(4):588–94, Jul 2000.Google Scholar
  75. 75.
    Pollack, R. J., A. E. Kiszewski and A. Spielman (2002). “Repelling mosquitoes." N Engl J Med 347(1): 2–3.PubMedGoogle Scholar
  76. 76.
    Pollack, R. J., S. R. Telford, 3rd and A. Spielman (1993). “Standardization of medium for culturing Lyme disease spirochetes." J Clin Microbiol 31(5): 1251–5.PubMedGoogle Scholar
  77. 77.
    Preac-Mursic, V., B. Wilske and G. Schierz (1986). “European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibility." Zentralbl Bakteriol Mikrobiol Hyg [A] 263(1–2): 112–8.Google Scholar
  78. 78.
    Pretorius, A. M., M. Jensenius, F. Clarke and S. H. Ringertz (2003). “Repellent efficacy of DEET and KBR 3023 against Amblyomma hebraeum (Acari: Ixodidae)." J Med Entomol 40(2): 245–8.PubMedGoogle Scholar
  79. 79.
    Preac Mursic, V., W. Marget, et al. (1996). “Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis." Infection 24(1): 9–16.Google Scholar
  80. 80.
    Preac-Mursic, V., K. Weber, et al. (1989). “Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis." Infection 17(6): 355–9.PubMedGoogle Scholar
  81. 81.
    Priem, S., G. R. Burmester, et al. (1998). “Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting Lyme arthritis after antibiotic therapy." Ann Rheum Dis 57(2): 118–21.PubMedGoogle Scholar
  82. 82.
    Probert, W. S. and B. J. Johnson (1998). “Identification of a 47 kDa fibronectin-binding protein expressed by Borrelia burgdorferi isolate B31." Mol Microbiol 30(5): 1003–15.PubMedGoogle Scholar
  83. 83.
    Purser, J. E., M. B. Lawrenz, M. J. Caimano, J. K. Howell, J. D. Radolf and S. J. Norris (2003). “A plasmid-encoded nicotinamidase (PncA) is essential for infectivity of Borrelia burgdorferi in a mammalian host." Mol Microbiol 48(3): 753–64.PubMedGoogle Scholar
  84. 84.
    Purser, J. E. and S. J. Norris (2000). “Correlation between plasmid content and infectivity in Borrelia burgdorferi." Proc Natl Acad Sci U S A 97(25): 13865–70.PubMedGoogle Scholar
  85. 85.
    Ramamoorthi, N., S. Narasimhan, U. Pal, F. Bao, X. F. Yang, D. Fish, J. Anguita, M. V. Norgard, F. S. Kantor, J. F. Anderson, R. A. Koski and E. Fikrig (2005). “The Lyme disease agent exploits a tick protein to infect the mammalian host." Nature 436(7050): 573–7.PubMedGoogle Scholar
  86. 86.
    Rothermel, H., T. R. Hedges, 3rd and A. C. Steere (2001). “Optic neuropathy in children with Lyme disease." Pediatrics 108(2): 477–81.PubMedGoogle Scholar
  87. 87.
    Schlesinger, P. A., P. H. Duray, B. A. Burke, A. C. Steere and M. T. Stillman (1985). “Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi." Ann Intern Med 103(1): 67–8.PubMedGoogle Scholar
  88. 88.
    Schulze, T. L., R. A. Jordan, R. W. Hung, R. C. Taylor, D. Markowski and M. S. Chomsky (2001). “Efficacy of granular deltamethrin against Ixodes scapularis and Amblyomma americanum (Acari: Ixodidade) nymphs." J Med Entomol 38(2): 344–6.PubMedGoogle Scholar
  89. 89.
    Shah, S. S., T. E. Zaoutis, J. Turnquist, R. L. Hodinka and S. E. Coffin (2005). “Early differentiation of Lyme from enteroviral meningitis." Pediatr Infect Dis J 24(6): 542–5.PubMedGoogle Scholar
  90. 90.
    Shapiro, E. D., M. A. Gerber, N. B. Holabird, A. T. Berg, H. M. Feder, Jr., G. L. Bell, P. N. Rys and D. H. Persing (1992). “A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites." N Engl J Med 327(25): 1769–73.PubMedGoogle Scholar
  91. 91.
    Silver, H. M. (1997). “Lyme disease during pregnancy." Infect Dis Clin North Am 11(1): 93–7.PubMedGoogle Scholar
  92. 92.
    Singh, S. K. and H. J. Girschick (2004). “Lyme borreliosis: from infection to autoimmunity." Clin Microbiol Infect 10(7): 598–614.PubMedGoogle Scholar
  93. 93.
    Stafford, K. C., 3rd (1991). “Effectiveness of carbaryl applications for the control of Ixodes dammini (Acari: Ixodidae) nymphs in an endemic residential area." J Med Entomol 28(1): 32–6.PubMedGoogle Scholar
  94. 94.
    Steere, A. C. (1989). “Lyme disease." N Engl J Med 321(9): 586–96.PubMedGoogle Scholar
  95. 95.
    Steere, A. C., W. P. Batsford, M. Weinberg, J. Alexander, H. J. Berger, S. Wolfson and S. E. Malawista (1980). “Lyme carditis: cardiac abnormalities of Lyme disease." Ann Intern Med 93(1):8–16.PubMedGoogle Scholar
  96. 96.
    Steere, A. C., R. T. Schoen and E. Taylor (1987). “The clinical evolution of Lyme arthritis." Ann Intern Med 107(5): 725–31.PubMedGoogle Scholar
  97. 97.
    Steere, A. C., V. K. Sikand, F. Meurice, D. L. Parenti, E. Fikrig, R. T. Schoen, J. Nowakowski, C. H. Schmid, S. Laukamp, C. Buscarino and D. S. Krause (1998). “Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group." N Engl J Med 339(4): 209–15.PubMedGoogle Scholar
  98. 98.
    Steere, A. C., S. E. Malawista, D. R. Snydman, R. E. Shope, W. A. Andiman, M. R. Ross and F. M. Steele (1977). ``Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities.’ Arthritis Rheum. 20(1):7–17, Jan–Feb 1977.Google Scholar
  99. 99.
    Stevenson, B., T. G. Schwan and P. A. Rosa (1995). “Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi." Infect Immun 63(11): 4535–9.PubMedGoogle Scholar
  100. 100.
    Straubinger, R. K., A. F. Straubinger, et al. (2000). “Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: An experimental study." J Infect Dis 181(3): 1069–81.PubMedGoogle Scholar
  101. 101.
    Straubinger, R. K., A. F. Straubinger, et al. (1998). “Clinical manifestations, pathogenesis, and effect of antibiotic treatment on Lyme borreliosis in dogs." Wiener Klinische Wochenschrift 110(24): 874–81.PubMedGoogle Scholar
  102. 102.
    Straubinger, R. K., B. A. Summers, et al. (1997). “Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment." J Clin Microbiol 35(1): 111–6.PubMedGoogle Scholar
  103. 103.
    Strle, F., V. Preac-Mursic, et al. (1993). “Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings." Infection 21(2): 83–8.PubMedGoogle Scholar
  104. 104.
    Strobino, B., S. Abid and M. Gewitz (1999). “Maternal Lyme disease and congenital heart disease: A case-control study in an endemic area." Am J Obstet Gynecol 180(3 Pt 1): 711–6.PubMedGoogle Scholar
  105. 105.
    Strother, K. O., A. Broadwater and A. De Silva (2005). “Plasmid requirements for infection of ticks by Borrelia burgdorferi." Vector Borne Zoonotic Dis 5(3): 237–45.PubMedGoogle Scholar
  106. 106.
    Tothova, S. M., S. Bonin, G. Trevisan and G. Stanta (2006). “Mycosis fungoides: is it a Borrelia burgdorferi-associated disease?" Br J Cancer 94(6): 879–83.Google Scholar
  107. 107.
    Tugwell, P., D. T. Dennis, A. Weinstein, G. Wells, B. Shea, G. Nichol, R. Hayward, R. Lightfoot, P. Baker and A. C. Steere (1997). “Laboratory evaluation in the diagnosis of Lyme disease." Ann Intern Med 127(12): 1109–23.PubMedGoogle Scholar
  108. 108.
    United States General Accounting Office (2001). Report to Congressional Requesters. ``Lyme Disease. HSS Programs and Resources.’ GAO-01-755. p11–15, June 2001. http://www.gao.gov/new.items/d01755.pdf.
  109. 109.
    United States Environmental Protection Agency (2005). EPA Reg. No. 121-OR. Review of acute toxicity data for Cutter Insect Repellant 15KP, EPA file symbol 121-OR, 15 March 2005.http://www.epa.gov/pesticides/foia/reviews/070705/070705-2005-03-15a.pdf.
  110. 110.
    Varela, A. S., M. P. Luttrell, E. W. Howerth, V. A. Moore, W. R. Davidson, D. E. Stallknecht and S. E. Little (2004). “First culture isolation of Borrelia lonestari, putative agent of southern tick-associated rash illness." J Clin Microbiol 42(3): 1163–9.PubMedGoogle Scholar
  111. 111.
    von Lackum, K., J. C. Miller, T. Bykowski, S. P. Riley, M. E. Woodman, V. Brade, P. Kraiczy, B. Stevenson and R. Wallich (2005). “Borrelia burgdorferi regulates expression of complement regulator-acquiring surface protein 1 during the mammal-tick infection cycle." Infect Immun 73(11): 7398–405.Google Scholar
  112. 112.
    Weber, K. (2001). “Aspects of Lyme borreliosis in Europe." Eur J Clin Microbiol Infect Dis 20(1): 6–13.PubMedGoogle Scholar
  113. 113.
    Weber, K., H. J. Bratzke, U. Neubert, B. Wilske and P. H. Duray (1988). “Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy." Pediatr Infect Dis J 7(4): 286–9.PubMedGoogle Scholar
  114. 114.
    Weber, K. (1996). “Treatment failure in erythema migrans--a review." Infection 24(1): 73–5.PubMedGoogle Scholar
  115. 115.
    World Heath Organization. Veterinary Public Health Unit (1995). “WHO Workshops on Lyme Borreliosis, Diagnosis and Surveillance.” WHO/CDS/VPH/95.141.p.5–8,June1995.http://whqlibdoc.who.int/hq/1995/WHO_CDS_VPH_95.141.pdf.
  116. 116.
    Wormser, G. P., R. J. Dattwyler, E. D. Shapiro, J. J. Halperin, A. C. Steere, M. S. Klempner, P. J. Krause, J. S. Bakken, F. Strle, G. Stanek, L. Bockenstedt, D. Fish, J. S. Dumler and R. B. Nadelman (2006). “The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America." Clin Infect Dis 43(9): 1089–134.PubMedGoogle Scholar
  117. 117.
    Wormser, G. P., E. Masters, D. Liveris, J. Nowakowski, R. B. Nadelman, D. Holmgren, S. Bittker, D. Cooper, G. Wang and I. Schwartz (2005). “Microbiologic evaluation of patients from Missouri with erythema migrans." Clin Infect Dis 40(3): 423–8.PubMedGoogle Scholar
  118. 118.
    Wormser, G. P., E. Masters, J. Nowakowski, D. McKenna, D. Holmgren, K. Ma, L. Ihde, L. F. Cavaliere and R. B. Nadelman (2005). “Prospective clinical evaluation of patients from missouri and new york with erythema migrans-like skin lesions." Clin Infect Dis 41(7): 958–65.PubMedGoogle Scholar
  119. 119.
    Wormser, G. P., R. B. Nadelman, R. J. Dattwyler, D. T. Dennis, E. D. Shapiro, A. C. Steere, T. J. Rush, D. W. Rahn, P. K. Coyle, D. H. Persing, D. Fish and B. J. Luft (2000). “Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America." Clin Infect Dis 31 Suppl 1: 1–14.Google Scholar
  120. 120.
    Ziska, M.H. (1996). “Disseminated Lyme Disease and pregnancy.” 9th Annual International Conference on Lyme Borreliosis and Other Tick Borne Disorders. Boston, MA.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Infectious Diseases, Division of Geographic Medicine and Infectious DiseasesTufts-New England Medical CenterBostonUSA
  2. 2.MD, Associate Professor of Medicine, Division of Geographic Medicine and Infectious DiseasesTufts-New England Medical CenterBostonUSA

Personalised recommendations